Compile Data Set for Download or QSAR
Found 176 with Last Name = 'busujima' and Initial = 't'
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159725(US9035059, 19-4)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159734(US9035059, 23-1 | US9035059, 24-1/24-2)copy SMILEScopy InChI
Affinity DataIC50: 4nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159724(US9035059, 19-3)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159732(US9035059, 20-4)copy SMILEScopy InChI
Affinity DataIC50: 5nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159705(US9035059, 18-7)copy SMILEScopy InChI
Affinity DataIC50: 7nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159711(US9035059, 18-16)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159740(US9035059, 24-11 | US9035059, 24-5/24-6)copy SMILEScopy InChI
Affinity DataIC50: 10nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159736(US9035059, 23-3)copy SMILEScopy InChI
Affinity DataIC50: 13nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159734(US9035059, 23-1 | US9035059, 24-1/24-2)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159730(US9035059, 20-2)copy SMILEScopy InChI
Affinity DataIC50: 14nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159735(US9035059, 23-2)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159657(US9035059, 7-76)copy SMILEScopy InChI
Affinity DataIC50: 16nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159729(US9035059, 19-12)copy SMILEScopy InChI
Affinity DataIC50: 23nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159701(US9035059, 17-5)copy SMILEScopy InChI
Affinity DataIC50: 24nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159636(US9035059, 6-75)copy SMILEScopy InChI
Affinity DataIC50: 24nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159682(US9035059, 10-5/10-6)copy SMILEScopy InChI
Affinity DataIC50: 25nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159681(US9035059, 10-3/10-4)copy SMILEScopy InChI
Affinity DataIC50: 26nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159708(US9035059, 18-12)copy SMILEScopy InChI
Affinity DataIC50: 26nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159624(US9035059, 6-33)copy SMILEScopy InChI
Affinity DataIC50: 26nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159727(US9035059, 19-8)copy SMILEScopy InChI
Affinity DataIC50: 28nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159615(US9035059, 6-17)copy SMILEScopy InChI
Affinity DataIC50: 28nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159707(US9035059, 18-11)copy SMILEScopy InChI
Affinity DataIC50: 29nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159666(US9035059, 8-5)copy SMILEScopy InChI
Affinity DataIC50: 29nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159734(US9035059, 23-1 | US9035059, 24-1/24-2)copy SMILEScopy InChI
Affinity DataIC50: 29nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159723(US9035059, 19-2)copy SMILEScopy InChI
Affinity DataIC50: 30nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159622(US9035059, 6-31)copy SMILEScopy InChI
Affinity DataIC50: 31nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159623(US9035059, 6-32)copy SMILEScopy InChI
Affinity DataIC50: 31nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159683(US9035059, 10-7/10-8)copy SMILEScopy InChI
Affinity DataIC50: 31nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159718(US9035059, 18-25)copy SMILEScopy InChI
Affinity DataIC50: 33nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159741(US9035059, 24-7/24-8)copy SMILEScopy InChI
Affinity DataIC50: 34nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159616(US9035059, 6-18)copy SMILEScopy InChI
Affinity DataIC50: 35nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159667(US9035059, 8-6)copy SMILEScopy InChI
Affinity DataIC50: 35nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159625(US9035059, 6-34)copy SMILEScopy InChI
Affinity DataIC50: 36nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159702(US9035059, 17-6)copy SMILEScopy InChI
Affinity DataIC50: 39nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159681(US9035059, 10-3/10-4)copy SMILEScopy InChI
Affinity DataIC50: 39nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159633(US9035059, 6-64)copy SMILEScopy InChI
Affinity DataIC50: 40nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159699(US9035059, 17-1)copy SMILEScopy InChI
Affinity DataIC50: 40nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159739(US9035059, 24-3/24-4)copy SMILEScopy InChI
Affinity DataIC50: 42nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159685(US9035059, 10-11 | US9035059, 10-12)copy SMILEScopy InChI
Affinity DataIC50: 42nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159646(US9035059, 7-32)copy SMILEScopy InChI
Affinity DataIC50: 42nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159704(US9035059, 18-6)copy SMILEScopy InChI
Affinity DataIC50: 43nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159687(US9035059, 10-15/10-16)copy SMILEScopy InChI
Affinity DataIC50: 44nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159682(US9035059, 10-5/10-6)copy SMILEScopy InChI
Affinity DataIC50: 44nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159659(US9035059, 7-81)copy SMILEScopy InChI
Affinity DataIC50: 45nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159700(US9035059, 17-2)copy SMILEScopy InChI
Affinity DataIC50: 45nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159680(US9035059, 9-24)copy SMILEScopy InChI
Affinity DataIC50: 46nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159679(US9035059, 9-23)copy SMILEScopy InChI
Affinity DataIC50: 46nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159630(US9035059, 6-48)copy SMILEScopy InChI
Affinity DataIC50: 49nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159634(US9035059, 6-65)copy SMILEScopy InChI
Affinity DataIC50: 51nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM159651(US9035059, 7-56)copy SMILEScopy InChI
Affinity DataIC50: 52nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2B856WHUS Patent
Displayed 1 to 50 (of 176 total ) | Next | Last >>
Jump to: